share_log

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.9%)

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.9%)

SC 13G/A:超過5%持股股東披露文件(修正)-BlackRock, Inc.(4.9%)
美股SEC公告 ·  05/09 02:24

牛牛AI助理已提取核心訊息

On April 30, 2024, BlackRock, Inc., a Delaware-based investment management corporation, filed an amended Schedule 13G with the Securities and Exchange Commission (SEC), indicating a change in its holdings of Cardio Diagnostics Holdings Inc. common stock. The filing, which is a requirement under the Securities Exchange Act of 1934 for certain ownership thresholds, shows that BlackRock now beneficially owns 1,067,062 shares, representing 4.9% of the company's class of common stock. This marks a decrease in ownership, as BlackRock has checked the box indicating it no longer holds more than 5% of the class of securities. The filing was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., and the information provided was certified as true and complete to the best of the signatory's knowledge.
On April 30, 2024, BlackRock, Inc., a Delaware-based investment management corporation, filed an amended Schedule 13G with the Securities and Exchange Commission (SEC), indicating a change in its holdings of Cardio Diagnostics Holdings Inc. common stock. The filing, which is a requirement under the Securities Exchange Act of 1934 for certain ownership thresholds, shows that BlackRock now beneficially owns 1,067,062 shares, representing 4.9% of the company's class of common stock. This marks a decrease in ownership, as BlackRock has checked the box indicating it no longer holds more than 5% of the class of securities. The filing was signed by Spencer Fleming, Attorney-In-Fact for BlackRock, Inc., and the information provided was certified as true and complete to the best of the signatory's knowledge.
2024年4月30日,總部位於特拉華州的投資管理公司貝萊德公司向美國證券交易委員會(SEC)提交了經修訂的附表13G,表明其持有的Cardio Diagnostics Holdings Inc.普通股發生了變化。該文件是1934年《證券交易法》對某些所有權門檻的要求,顯示貝萊德現在實益擁有1,067,062股股票,佔公司普通股類別的4.9%。這標誌着所有權的減少,因爲貝萊德已經勾選了表明其持有該類別證券的比例不再超過5%的複選框。該文件由貝萊德公司事實律師斯賓塞·弗萊明簽署,據簽署人所知,所提供的信息經認證爲真實和完整。
2024年4月30日,總部位於特拉華州的投資管理公司貝萊德公司向美國證券交易委員會(SEC)提交了經修訂的附表13G,表明其持有的Cardio Diagnostics Holdings Inc.普通股發生了變化。該文件是1934年《證券交易法》對某些所有權門檻的要求,顯示貝萊德現在實益擁有1,067,062股股票,佔公司普通股類別的4.9%。這標誌着所有權的減少,因爲貝萊德已經勾選了表明其持有該類別證券的比例不再超過5%的複選框。該文件由貝萊德公司事實律師斯賓塞·弗萊明簽署,據簽署人所知,所提供的信息經認證爲真實和完整。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。